Agile Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
22 août 2017 07h30 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Aug. 22, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company, announced today that Al Altomari, Chairman and CEO will...
Agile Therapeutics to Present at Liolios 6th Annual Gateway Conference
16 août 2017 16h10 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Aug. 16, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company, announced today that Al Altomari, Chairman and CEO will...
Agile Therapeutics Reports Additional Phase 3 SECURE Study Results Relating to Twirla® at ACOG 2017
06 mai 2017 14h05 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., May 06, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women’s healthcare company, today announced the presentation of additional results of its Phase 3 SECURE...
Agile Therapeutics Announces Presentation of SECURE Phase 3 Data at the 2017 Congress on Women’s Health
27 avr. 2017 07h30 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., April 27, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (NASDAQ:AGRX), a women's healthcare company announced today that a presentation entitled “An Update on Hormonal...
Agile Therapeutics to Present at Biotech Showcase 2017
22 déc. 2016 08h00 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Dec. 22, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) announced today that its Chief Executive Officer, Al Altomari will present at the Biotech Showcase 2017 on...
Agile Therapeutics Reports Third Quarter 2016 Financial Results and Announces Completion of Subject Visits for Twirla® Phase 3 SECURE Clinical Trial
07 nov. 2016 16h10 HE
|
Agile Therapeutics, Inc.
Top-Line Data Expected in Early January 2017; Resubmission Planned for First Half 2017 Cash Expected to Fund Operations Through the End of 2017 PRINCETON, N.J., Nov. 07, 2016 (GLOBE...
Agile Therapeutics Reports Second Quarter 2016 Financial Results
08 août 2016 16h05 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics to Present at the Cantor Fitzgerald’s 2nd Annual Healthcare Conference
23 juin 2016 16h10 HE
|
Agile Therapeutics, Inc.
PRINCETON, N.J., June 23, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of...